Non-opioid analgesic / antipyretic · ATC N02BB02. Every registered pack in the UAE with published prices, agents and manufacturers; the price spread between brands; the same medicine in India, the US and the EU; and same‑class alternatives.
Unit price to public, same form and strength, registered brands only. Green = cheapest. The spread is the gap a class‑level tender or formulary switch can usually close.
India: India brand MRP (median of 2) ₹1.61 ($0.019) per tablet at 500mg. US prices are not published by FDA; EU prices are national. Ask us for a landed‑cost benchmark.
₹0.55–1.61 per unit across 5 priced packs. MRP as printed on pack (indicative, open dataset 2024); combinations listed after single‑ingredient brands. Showing 5 of 5.
| Brand | Manufacturer | Strength | Pack | MRP ₹ | ₹ / unit |
|---|---|---|---|---|---|
| Novalgin RC 0.5% Injection | Sanofi India Ltd | 0.5% | vial of 30 ml Injection | ₹30.40 | ₹1.01 |
| Andep 0.5mg Tablet | Ravian Pharmaceuticals Ltd | 0.5mg | strip of 10 tablets | ₹12.44 | ₹1.24 |
| ANALGIN 500MG TABLET | Alkem Laboratories Ltd | 500mg | strip of 10 tablets | ₹5.50 | ₹0.55 |
| Bral 500mg Tablet | Micro Labs Ltd | 500mg | strip of 10 tablets | ₹16.08 | ₹1.61 |
| Ultragin 500mg Injection | Pfizer Ltd | 500mg | vial of 30 ml Injection | ₹25.78 | ₹0.86 |
Non-opioid analgesic / antipyretic · Pain & anaesthesia · ATC N02BB02. Interchangeable for fever/mild pain; paracetamol is the formulary default.
Cross‑class alternatives: NSAIDs (different risk profile).
Procurement note: Not registered in some markets; agranulocytosis risk.
Usual forms: 500 mg tab; 1 g/2 ml inj.
Brands · India: Novalgin, Analgin
Brands · UAE/GCC seen in tenders: Novalgin
None are Active on the UAE register at this release.
No published UAE price at this release.
No matching‑strength India reference price is available for a per‑unit comparison.
See the register tab.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Data: DoH Abu Dhabi Shafafiya drug list (2 Nov 2026); FDA NDC Directory and Orange Book (Sept–Nov 2026); NPPA and PMBI Jan Aushadhi (Nov 2026); EMA (Nov 2026); WHO ATC/DDD 2026; Consulting Wallah class repository. For information only; verify with the regulator before purchase or dispensing. No prescribing advice. © Consulting Wallah — CC BY‑NC‑ND; bulk extraction not permitted.